Find Clinical Trials & Studies

Visit the Research & Education Institute

Study With (225Ac)Ac-FL-020 in mCRPC Participants

I'm Interested!

Please call
1-866-373-1464

A Phase 1, First-in-Human, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of [225Ac]Ac-FL-020 in Participants With mCRPC.

Sex: Male
Age: Adult (18 - 64), Older Adult (65+)
Accepting Healthy People: No
Type: Interventional / Therapeutic
Trial Phase: Phase I
Conditions Being Studied: Cancer - Prostate

Study Purpose

The purpose of this study is to evaluate the safety, therapeutic effect, and pharmacokinetics of [225Ac]Ac-FL-020 in participants with metastatic castration-resistant prostate cancer (mCRPC).

Principal Investigator
Pedro Barata MD

Department/Division
Cancer (Genitourinary)

UH IRB: STUDY20251326 / Pro00091143
StudyID: FLTN1825
ClinicalTrials.gov: NCT06492122

I'm Interested!

Please call
1-866-373-1464

Questions or concerns? We're here to help.

Non-cancer Trials: 1-833-78TRIAL or Contact Us Online

Cancer Trials: 1-866-373-1464